Literature DB >> 11194703

Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?

G Faglia1, M Arosio, S Porretti.   

Abstract

Estrogens locally generated from androgen precursors due to the action of aromatase play a main role in epiphyseal cartilage fusion. Treatment with an aromatase inhibitor (anastrozole, 1 mg/day for 3 yr) in a boy previously operated on for a hamartoma causing precocious puberty and presenting with advanced bone maturation and nearly fused epiphyseal cartilages, slowed cartilage fusion consenting a higher final stature than expected (164.4 cm vs 158.4 cm). It is suggested that treatment with aromatase inhibitors, alone or in combination with rh-GH, may also be useful in children with constitutional short stature in order to delay epiphyseal closure and improve the final height.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11194703     DOI: 10.1007/BF03345059

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons.

Authors:  H Jung; P Carmel; M S Schwartz; J W Witkin; K H Bentele; M Westphal; J H Piatt; M E Costa; A Cornea; Y J Ma; S R Ojeda
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

Review 2.  Estrogen: consequences and implications of human mutations in synthesis and action.

Authors:  M M Grumbach; R J Auchus
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

3.  Effect of testosterone and estradiol in a man with aromatase deficiency.

Authors:  C Carani; K Qin; M Simoni; M Faustini-Fustini; S Serpente; J Boyd; K S Korach; E R Simpson
Journal:  N Engl J Med       Date:  1997-07-10       Impact factor: 91.245

4.  Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.

Authors:  T Ishii; S Sato; M Anzo; G Sasaki; T Hasegawa; S Tamai; N Matsuo
Journal:  Eur J Pediatr       Date:  1999-11       Impact factor: 3.183

Review 5.  Estrogen receptor null mice: what have we learned and where will they lead us?

Authors:  J F Couse; K S Korach
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

Review 6.  The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.

Authors:  A Hamilton; M Piccart
Journal:  Ann Oncol       Date:  1999-04       Impact factor: 32.976

7.  Bone has a sexually dimorphic response to aromatase deficiency.

Authors:  O K Oz; J E Zerwekh; C Fisher; K Graves; L Nanu; R Millsaps; E R Simpson
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

8.  Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.

Authors:  A M Pasquino; I Pucarelli; M Roggini; M Segni
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

9.  Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene.

Authors:  C R Fisher; K H Graves; A F Parlow; E R Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.

Authors:  E W Leschek; J Jones; K M Barnes; S C Hill; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

View more
  5 in total

Review 1.  Pesticides as the drivers of neuropsychotic diseases, cancers, and teratogenicity among agro-workers as well as general public.

Authors:  Seema Patel; Sushree Sangeeta
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-08       Impact factor: 4.223

2.  Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.

Authors:  Matthew D Stephen; Peter E Zage; Steven G Waguespack
Journal:  Int J Pediatr Endocrinol       Date:  2011-03-06

Review 3.  Aromatase inhibitors in pediatrics.

Authors:  Jan M Wit; Matti Hero; Susan B Nunez
Journal:  Nat Rev Endocrinol       Date:  2011-10-25       Impact factor: 43.330

Review 4.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 5.  Advances in pubertal growth and factors influencing it: Can we increase pubertal growth?

Authors:  Ashraf Soliman; Vincenzo De Sanctis; Rania Elalaily; Said Bedair
Journal:  Indian J Endocrinol Metab       Date:  2014-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.